Beyond Increased Risk: APOE4 a Direct Cause of AD?
Two copies of APOE4 may be more than just a risk factor for AD; the pair may cause the disease in 15%-20% of cases.
Stay updated with breaking news from Board Certification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two copies of APOE4 may be more than just a risk factor for AD; the pair may cause the disease in 15%-20% of cases.
For Black Americans, racial discrimination in midlife is associated with an increased risk of developing Alzheimer's disease later in life, new findings show.
As the treatment of obesity in the 21st century takes a monumental turn, the need for quality care is more pressing than ever: Tips for starting a new obesity-focused practice.
A once-daily injectable therapy of a fixed-ratio combination of insulin glargine and lixisenatide improved glycemic control, with low rates of hypoglycemia, in people with T2D in a real-world setting.
State laws that require PCPs to report patients with suspected dementia may result in delayed or missed diagnosis of the disorder, defeating the aim of improving road safety.